Achmea Investment Management B.V. raised its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 43.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 198,698 shares of the company's stock after purchasing an additional 59,836 shares during the quarter. Achmea Investment Management B.V. owned about 0.08% of Cardinal Health worth $23,500,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Cardinal Health by 35.2% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock valued at $3,871,000 after purchasing an additional 8,471 shares during the last quarter. CHURCHILL MANAGEMENT Corp boosted its holdings in shares of Cardinal Health by 1.5% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company's stock valued at $28,435,000 after purchasing an additional 3,576 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock valued at $633,298,000 after purchasing an additional 42,082 shares during the last quarter. Consolidated Planning Corp boosted its holdings in shares of Cardinal Health by 40.0% in the 4th quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock valued at $1,056,000 after purchasing an additional 2,552 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Cardinal Health by 2.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company's stock valued at $162,976,000 after acquiring an additional 33,388 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.
Wall Street Analyst Weigh In
CAH has been the topic of a number of research reports. Morgan Stanley raised their target price on shares of Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research note on Friday, January 31st. Argus set a $148.00 target price on shares of Cardinal Health in a research note on Tuesday, February 4th. Bank of America raised shares of Cardinal Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Mizuho initiated coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 target price on the stock. Finally, Citigroup raised their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research note on Friday, January 10th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and an average price target of $139.36.
View Our Latest Research Report on CAH
Cardinal Health Stock Down 0.5 %
Shares of CAH traded down $0.60 during midday trading on Thursday, hitting $126.24. The company had a trading volume of 1,664,620 shares, compared to its average volume of 2,465,115. The company's 50 day moving average price is $125.99 and its 200 day moving average price is $119.14. The stock has a market cap of $30.49 billion, a price-to-earnings ratio of 23.55, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84.
Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.60%. Cardinal Health's dividend payout ratio (DPR) is 37.69%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
